CEO & Director, Evidation Health

Deborah Kilpatrick

Deborah Kilpatrick, PhD is the Chief Executive Officer of Evidation Health in San Mateo, CA. TIME Magazine recently named Evidation to their list of innovations that will change health care and medicine in the 2020s. She is a Director for both the Task Force for Global Health and Sleep Number (NASDAQ: SNBR), serves on the Georgia Tech and Cal Poly Engineering Advisory Boards, and is a Fellow of the American Institute of Medical and Biological Engineering. Earlier in her career, Deborah held leadership roles at CardioDx and Guidant Corporation, where she was Research Fellow, Director of R&D, and Director of New Ventures in its Vascular Intervention Division prior to its acquisition by Boston Scientific. Deborah is a co-founder of the MedtechVision Conference held annually in Silicon Valley, and she has been named to FierceBiotech’s Top Women in Biotech, FierceMedicalDevice’s Top Women in Medtech, and Silicon Valley Business Journal’s 100 Women of Influence. She holds BS, MS and PhD degrees in mechanical engineering with a bioengineering focus from Georgia Tech.